medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2017, Number 1

<< Back Next >>

Rev ADM 2017; 74 (1)

Guideline to reduce the risk of transmission of Mycobacterium abscessus in clinical dental practice

Rivera SG, Padilla JC, Bonasso BPA, González SAJ, Martínez MHR

Language: Spanish
References: 18
Page: 6-10
PDF size: 189.45 Kb.


ABSTRACT

Biosafety measures are designed to reduce the risk of transmission of microorganisms from recognized or unrecognized sources of infection in dental procedures associated with the contamination of materials, apparatus, and/or instruments. One reemerging microorganism is Mycobacterium abscessus, which is an environmental bacterium that can cause serious health problems and therefore needs to be controlled and prevented.


REFERENCES

  1. Porvaznik I, Solovič I, Mokrý J. Non-tuberculous mycobacteria: classification, diagnostics, and therapy. Adv Exp Med Biol. 2017; 944: 19-25.

  2. Peralta G. Tobin-D’Angelo M, Parham A, Edison L, Lorentzon L, Smith C et al. Notes from the field: Mycobacterium abscessus infection among patients of a pediatric dentistry practice-Georgia, 2015. Morb Mortal Wkly Rep. 2016; 65: 355-356.

  3. Lévy-Frébault V, Portaels F. Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol. 1992; 42 (2): 315-323.

  4. Lapage SP, Sneath PHA, Lesel EF, Skerman VDB, Seeliger HPR, Clark WA. Appendix 2. Approved lists of bacterial names. In international code of nomenclature of bacteria. Revision. American Society for Microbiology. Washington (DC): ASM press; 1992. pp. 231-420.

  5. Eustace K, Jollife V, Sahota A, Gholam K. Cutaneous Mycobacterium abscessus infection following hair transplant. Clin Exp Dermatol. 2016; 41 (7): 768-770.

  6. Wallace RJ, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983; 5 (4): 657-679.

  7. Mougari F, Guglielmetti L, Raskie L, Sermet-Gaudelus I, Veziris N, Cambau E. Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Rev Anti Infect Ther. 2016; 14 (12): 1139-1154.

  8. Gubler JG, Salfinger M, von-Graevenitz A. Pseudoepidemic of non-tuberculous mycobacteria due to a contamined bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest. 1992; 101 (5): 1245-1249.

  9. Al-Anazi KA, Al-Jasser AM, Al-Anazi WK. Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. Front Oncol. 2014; 4: 311.

  10. Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P et al. Emergence and spread of a human-transmissible multidrug-resistant non tuberculous mycobacterium. Science. 2016; 354 (6313): 751-757.

  11. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol. 1990; 28 (10): 2234-2239.

  12. Fodor T, Szabó I. Effect of chlorhexidine gluconate on the survival of acid fast bacteria. Acta Microbiol Acad Sci Hung. 1980; 27 (4): 343-344.

  13. Center for Science Information. ADA Science Institute. Dental Unit Waterlines. 2016 [Actualización 19 de agosto de 2016]. Disponible en: http://www.ada.org/en/member-center/oral-health-topics/dental-unit-waterlines

  14. Cox M, Cohn PD, Beger PS. Aspectos de la calidad del agua. Salud y estética. En: Letterman RD, editor. American Water Works Association. España: McGraw-Hill Interamericana de España; 2002. pp. 47-130.

  15. US Environmental Protection Agency Office of Pesticide Programs. List of B: EPA’s registered tuberculocide products effective against Mycobacterium tuberculosis. 2014 [Obtenido el 16 de noviembre de 2016]. Disponible en: https://www.epa.gov/sites/production/files/201509/documents/list_b_tuberculocide.pdf

  16. Novosad SA, Beekmann SE, Polgreen PM, Mackey K, Winthrop KL. Treatment of Mycobacterium abscessus infection. Emerg Infect Dis. 2016; 22 (3): 511-514.

  17. Singh N, Yu VL. Successful treatment of pulmonary infection due to Mycobacterium chelonae: case report and review. Clin Inf Dis. 1992; 14: 156-161.

  18. Gobierno Federal, Salud, SEDENA, SEMAR. Diagnóstico y tratamiento de las infecciones por micobacterias no tuberculosas. Evidencias y recomendaciones. Catálogo maestro de guías de práctica clínica: IMSS-650-14. 2014 [Obtenido el 16 de noviembre de 2016]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/IMSS-650-14-MicobacteriosisNotuberculosa/650GER.pdf




2020     |     www.medigraphic.com